214 related articles for article (PubMed ID: 23223448)
21. LARGE expression augments the glycosylation of glycoproteins in addition to α-dystroglycan conferring laminin binding.
Zhang Z; Zhang P; Hu H
PLoS One; 2011 Apr; 6(4):e19080. PubMed ID: 21533062
[TBL] [Abstract][Full Text] [Related]
22. Dystroglycan function is a novel determinant of tumor growth and behavior in prostate cancer.
Mitchell A; Mathew G; Jiang T; Hamdy FC; Cross SS; Eaton C; Winder SJ
Prostate; 2013 Mar; 73(4):398-408. PubMed ID: 22996647
[TBL] [Abstract][Full Text] [Related]
23. A role for dystroglycan in the pathophysiology of acute leukemic cells.
Alonso-Rangel L; Benítez-Guerrero T; Martínez-Vieyra I; Cisneros B; Martínez-Tovar A; Winder SJ; Cerecedo D
Life Sci; 2017 Aug; 182():1-9. PubMed ID: 28591567
[TBL] [Abstract][Full Text] [Related]
24. Dystroglycan expression is reduced during prostate tumorigenesis and is regulated by androgens in prostate cancer cells.
Sgambato A; De Paola B; Migaldi M; Di Salvatore M; Rettino A; Rossi G; Faraglia B; Boninsegna A; Maiorana A; Cittadini A
J Cell Physiol; 2007 Nov; 213(2):528-39. PubMed ID: 17516554
[TBL] [Abstract][Full Text] [Related]
25. Hypoglycosylation of dystroglycan due to T192M mutation: a molecular insight behind the fact.
Bhattacharya S; Das A; Ghosh S; Dasgupta R; Bagchi A
Gene; 2014 Mar; 537(1):108-14. PubMed ID: 24361964
[TBL] [Abstract][Full Text] [Related]
26. Expression of dystroglycan correlates with tumor grade and predicts survival in renal cell carcinoma.
Sgambato A; Camerini A; Amoroso D; Genovese G; De Luca F; Cecchi M; Migaldi M; Rettino A; Valsuani C; Tartarelli G; Donati S; Siclari O; Rossi G; Cittadini A
Cancer Biol Ther; 2007 Dec; 6(12):1840-6. PubMed ID: 18087214
[TBL] [Abstract][Full Text] [Related]
27. Human natural killer-1 sulfotransferase (HNK-1ST)-induced sulfate transfer regulates laminin-binding glycans on α-dystroglycan.
Nakagawa N; Manya H; Toda T; Endo T; Oka S
J Biol Chem; 2012 Aug; 287(36):30823-32. PubMed ID: 22801424
[TBL] [Abstract][Full Text] [Related]
28. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
[TBL] [Abstract][Full Text] [Related]
29. A tumor suppressor function of laminin-binding alpha-dystroglycan.
Bao X; Fukuda M
Methods Enzymol; 2010; 479():387-96. PubMed ID: 20816178
[TBL] [Abstract][Full Text] [Related]
30. Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan.
Stevens E; Carss KJ; Cirak S; Foley AR; Torelli S; Willer T; Tambunan DE; Yau S; Brodd L; Sewry CA; Feng L; Haliloglu G; Orhan D; Dobyns WB; Enns GM; Manning M; Krause A; Salih MA; Walsh CA; Hurles M; Campbell KP; Manzini MC; ; Stemple D; Lin YY; Muntoni F
Am J Hum Genet; 2013 Mar; 92(3):354-65. PubMed ID: 23453667
[TBL] [Abstract][Full Text] [Related]
31. Adhesion of cultured bovine aortic endothelial cells to laminin-1 mediated by dystroglycan.
Shimizu H; Hosokawa H; Ninomiya H; Miner JH; Masaki T
J Biol Chem; 1999 Apr; 274(17):11995-2000. PubMed ID: 10207021
[TBL] [Abstract][Full Text] [Related]
32. Old World arenavirus infection interferes with the expression of functional alpha-dystroglycan in the host cell.
Rojek JM; Campbell KP; Oldstone MB; Kunz S
Mol Biol Cell; 2007 Nov; 18(11):4493-507. PubMed ID: 17761532
[TBL] [Abstract][Full Text] [Related]
33. Genes required for functional glycosylation of dystroglycan are conserved in zebrafish.
Moore CJ; Goh HT; Hewitt JE
Genomics; 2008 Sep; 92(3):159-67. PubMed ID: 18632251
[TBL] [Abstract][Full Text] [Related]
34. Altered expression of alpha-dystroglycan subunit in human gliomas.
Calogero A; Pavoni E; Gramaglia T; D'Amati G; Ragona G; Brancaccio A; Petrucci TC
Cancer Biol Ther; 2006 Apr; 5(4):441-8. PubMed ID: 16575202
[TBL] [Abstract][Full Text] [Related]
35. Dystroglycan loss disrupts polarity and beta-casein induction in mammary epithelial cells by perturbing laminin anchoring.
Weir ML; Oppizzi ML; Henry MD; Onishi A; Campbell KP; Bissell MJ; Muschler JL
J Cell Sci; 2006 Oct; 119(Pt 19):4047-58. PubMed ID: 16968749
[TBL] [Abstract][Full Text] [Related]
36. Loss of cell-surface laminin anchoring promotes tumor growth and is associated with poor clinical outcomes.
Akhavan A; Griffith OL; Soroceanu L; Leonoudakis D; Luciani-Torres MG; Daemen A; Gray JW; Muschler JL
Cancer Res; 2012 May; 72(10):2578-88. PubMed ID: 22589276
[TBL] [Abstract][Full Text] [Related]
37. Alpha-dystroglycan staining pattern and mortality in patients undergoing radical prostatectomy with lymph node positive prostate cancer.
Alzubaidi AN; Nepple KG; Vollstedt A; Dahmoush L; Ma D; Henry MD; Brown JA
Can J Urol; 2019 Dec; 26(6):10054-10060. PubMed ID: 31860423
[TBL] [Abstract][Full Text] [Related]
38. Localization and functional analysis of the LARGE family of glycosyltransferases: significance for muscular dystrophy.
Brockington M; Torelli S; Prandini P; Boito C; Dolatshad NF; Longman C; Brown SC; Muntoni F
Hum Mol Genet; 2005 Mar; 14(5):657-65. PubMed ID: 15661757
[TBL] [Abstract][Full Text] [Related]
39. LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies.
Barresi R; Michele DE; Kanagawa M; Harper HA; Dovico SA; Satz JS; Moore SA; Zhang W; Schachter H; Dumanski JP; Cohn RD; Nishino I; Campbell KP
Nat Med; 2004 Jul; 10(7):696-703. PubMed ID: 15184894
[TBL] [Abstract][Full Text] [Related]
40. Disruption of perlecan binding and matrix assembly by post-translational or genetic disruption of dystroglycan function.
Kanagawa M; Michele DE; Satz JS; Barresi R; Kusano H; Sasaki T; Timpl R; Henry MD; Campbell KP
FEBS Lett; 2005 Aug; 579(21):4792-6. PubMed ID: 16098969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
